Tuesday, August 4, 2009

Oncothyreon Names VP

Seattle-based Oncothyreon, a biotech firm developing treatments for cancer, reported this morning that it has appointed Diana Hausman as Vice President Clinical Development. Dr. Hausman joins the firm from Zymogentics, where she was most recently Senior Director of Clinical Research. Hausman has also served at Berlex. Oncothyreon said that Dr. Hausman will join the firm on September 1st.